畜牧兽医学报 ›› 2024, Vol. 55 ›› Issue (3): 1179-1191.doi: 10.11843/j.issn.0366-6964.2024.03.030

• 预防兽医 • 上一篇    下一篇

副猪革拉瑟菌影递送猪圆环病毒2型DNA二联疫苗的制备及小鼠免疫效果评价

王康, 刘格言, 王宇, 杨振, 唐欣巍, 曹三杰, 黄小波, 颜其贵, 伍锐, 赵勤, 杜森焱, 文心田, 文翼平*   

  1. 四川农业大学动物医学院 猪病研究中心, 成都 611130
  • 收稿日期:2023-06-02 出版日期:2024-03-23 发布日期:2024-03-27
  • 通讯作者: 文翼平,主要从事动物传染病研究,E-mail:wyp@sicau.edu.cn
  • 作者简介:王康(1998-),男,四川新津人,硕士,主要从事动物传染病研究,E-mail:wangkkang156@163.com;刘格言(1997-),女,辽宁铁东人,硕士,主要从事动物传染病研究,E-mail:pyliugeyan@163.com。
  • 基金资助:
    成都市科技项目(2022-YF06-00177)

Preparation of Glaesserella parasuis Ghosts Vaccine Delivering Porcine Circovirus Type 2 DNA Vaccine and Evaluation of Its Immunoprotective Effect in Mice

WANG Kang, LIU Geyan, WANG Yu, YANG Zhen, TANG Xinwei, CAO Sanjie, HUANG Xiaobo, YAN Qigui, WU Rui, ZHAO Qin, DU Senyan, WEN Xintian, WEN Yiping*   

  1. Research Center of Swine Disease, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 611130, China
  • Received:2023-06-02 Online:2024-03-23 Published:2024-03-27

摘要: 本研究旨在研制猪圆环病毒2型(PCV2)-副猪革拉瑟菌(GPS)二联菌影疫苗,并评价其在小鼠上的免疫保护效果。选择GPS 5型菌株SH0165作为疫苗株,利用氢氧化钠最低抑菌浓度法将其制备成菌影,再将PCV2的ORF2基因克隆至pEGFP-N1真核表达质粒,将GPS菌影作为PCV2 DNA疫苗的载体,构建PCV2-GPS二联菌影疫苗,设计了商品化疫苗组、PCV2-GPS二联菌影疫苗组、菌影组、质粒组、PBS组、空白组,对4周龄BALB/c小鼠进行免疫,测定免疫后PCV2和GPS的IgG抗体效价、PCV2中和抗体、脏器中PCV2病毒载量、血清杀菌率、GPS攻毒保护率以及血清中细胞因子(IFN-γ、IL-12)水平。结果显示:二联菌影疫苗组小鼠血清中PCV2和GPS的IgG抗体水平显著增高,PCV2中和抗体滴度提高,PCV2攻毒后的小鼠淋巴结和肺脏中病毒载量下降,血清杀菌率显著提高,GPS攻毒后免疫保护率达70%(7/10),小鼠血清中IFN-γ含量显著上调。综上表明,PCV2-GPS二联菌影疫苗显著激活了小鼠对PCV2和GPS的体液免疫反应和细胞免疫反应,且能够抑制PCV2在小鼠体内的增殖,对感染GPS的小鼠达到较好的保护效果,为新型安全高效的PCV2、GPS联合疫苗的研制提供了生物材料和实验数据。

关键词: 猪圆环病毒2型, ORF2基因, 副猪革拉瑟菌, 菌影, 小鼠, 免疫保护

Abstract: The aim of this study was to develop a combined vaccine against porcine circovirus type 2 (PCV2) and Glaesserella parasuis (GPS), and to evaluate its immune protective effect in mice. We selected SH0165, a type 5 strain of GPS, as the vaccine strain. The G. parasuis ghosts were generated by chemically-induced lysis and the method is based on minimum inhibitory concentration (MIC) of sodium hydroxide (NaOH). Then, the ORF2 gene of PCV2 was cloned into the pEGFP-N1 vector. We developed a PCV2-GPS combined vaccine by using G. parasuis ghosts as vehicle for pEGFP-ORF2. Furthermore, four-week-old BALB/c mice were divided into commercial vaccine group, PCV2-GPS combined vaccine group, G. parasuis vaccine group, pEGFP-ORF2 group, PBS group, and blank group. The IgG antibody level against PCV2 and GPS, neutralization antibody against PCV2, PCV2 viral load of organs in mice, serum bactericidal activities, challenge protection efficacy, and level of cytokines (IFN-γ, IL-12) in serum were measured after immunization. The results showed that PCV2-GPS combined vaccine elicited significantly higher levels of IgG antibody response of PCV2 and GPS, neutralization antibody titer of PCV2, bactericidal activities and higher levels of IFN-γ than those of the control group. After PCV2 challenge, PCV2-GPS combined vaccine-immunized mice showed lower viral load in lymph nodes and lungs than the control group, and after challenge infection with GPS, immune protection efficacy of mice immunized was 70% (7/10). In conclusion, the PCV2-GPS combined vaccine significantly activated both humoral and cell-mediated immune responses, and inhibited the proliferation of PCV2 in mice, achieving a better protective effect in mice infected with GPS. The results provide biological materials and experimental data for the development of new, safe and efficient combined vaccines against porcine circovirus type 2 and Glaesserella parasuis.

Key words: porcine circovirus type 2, ORF2 gene, Glaesserella parasuis, bacterial ghost, mice, immunoprotection

中图分类号: